5.2     Company Stockholders’ Meeting. 
<omitted> 
(f)     Notwithstanding anything to the contrary contained in Section 5.2(e), at any time prior to the adoption of this Agreement by the Required Company Stockholder Vote:   (i)     the Company’s board of directors may make a Company Adverse Recommendation Change and/or cause the Company to terminate this Agreement in accordance with Section 8.1(j) and, concurrently with such termination, approve, and cause the Company to enter into, a Specified Company Acquisition Agreement in accordance with, and subject to compliance with, the provisions of Section 8.1(j) if (and only if): (A) an unsolicited, bona fide, written Company Acquisition Proposal is made to the Company after the date of this Agreement and is not withdrawn; (B) the Company’s board of directors determines in good faith, after having taken into account the advice of an independent financial advisor of nationally recognized reputation (which, for the avoidance of doubt, shall include Qatalyst) and the advice of the Company’s outside legal counsel, that such Company Acquisition Proposal constitutes a Company Superior Offer; (C) the Company’s board of directors determines that, in light of such Company Superior Offer, the failure to make a Company Adverse Recommendation Change or the failure to terminate this Agreement pursuant to Section 8.1(j) in order to accept such Company Superior Offer would be inconsistent with its fiduciary obligations to the Company’s stockholders under applicable Delaware law; (D) no less than three (3) calendar days prior to making such Company Adverse Recommendation Change or terminating this Agreement pursuant to Section 8.1(j) in order to accept such Company Superior Offer, the Company’s board of directors delivers to Marvell a written notice (a “Company Recommendation Change Notice”) (1) stating that the Company has received a Company Superior Offer that did not result from a breach of any of the provisions of Section 4.3, (2) stating that the Company’s board of directors intends to make a Company Adverse Recommendation Change as a result of such Company Superior Offer (and describing the intended Company Adverse Recommendation Change) or intends to terminate this Agreement pursuant t o Section 8.1(j) in order to accept such Company Superior Offer, (3) specifying the material terms and conditions of such Company Superior Offer, including the identity of the Person making such Company Superior Offer and (4) attaching copies of the most current and complete draft of any Contract relating to such Company Superior Offer and all other documents and communications relating to such Company Superior Offer; (E) for three (3) calendar days after receipt by Marvell of such Company Recommendation Change Notice, the Company’s board of directors has not made a Company Adverse Recommendation Change and the Company has not attempted to terminate this Agreement pursuant to Section 8.1(j); (F) throughout such three (3) calendar day period, the Company engages (to the extent requested by Marvell) in good faith negotiations with Marvell to amend this Agreement in such a manner that the failure to make a Company Adverse Recommendation Change or the failure to terminate this Agreement pursuant to Section 8.1(j) in order to accept such Company Superior Offer would not be inconsistent with the fiduciary obligations of the Company’s board of directors to the Company’s stockholders under applicable Delaware law; and (G) at the time of such Company Adverse Recommendation Change or the termination of this Agreement pursuant to Section 8.1(j) in order to accept such Company Superior Offer, the Company’s board of directors determines in good faith, after taking into account the advice of an independent financial advisor of nationally recognized reputation (which, for the avoidance of doubt, shall include Qatalyst) and the advice of the Company’s outside legal counsel, that the failure to make a Company Adverse Recommendation Change or the failure to terminate this Agreement pursuant to Section 8.1(j) in order to accept such Company Superior Offer would still be inconsistent with the fiduciary obligations of the Company’s board of directors to the Company’s stockholders under applicable Delaware law in light of such Company Superior Offer; provided, however, that when making such determination, the Company’s board of directors shall be obligated to consider any changes to the terms of this Agreement proposed by Marvell in writing as a result of the negotiations required by clause “(F)” above; or (Page 65)

5.2     Company Stockholders’ Meeting. 
<omitted> 
(f)     <omitted>   (i)     the Company’s board of directors may make a Company Adverse Recommendation Change <omitted> if (and only if): <omitted> 

(D) no less than three (3) calendar days prior to making such Company Adverse Recommendation Change <omitted> , the Company’s board of directors delivers to Marvell a <omitted>  notice (a “Company Recommendation Change Notice”)  <omitted> (2) stating that the Company’s board of directors intends to make a Company Adverse Recommendation Change as a result of such Company Superior Offer (and describing the intended Company Adverse Recommendation Change) <omitted>  (E) for three (3) calendar days after receipt by Marvell of such Company Recommendation Change Notice, the Company’s board of directors has not made a Company Adverse Recommendation Change <omitted> ; (F) throughout such three (3) calendar day period, the Company engages (to the extent requested by Marvell) in good faith negotiations with Marvell to amend this Agreement (Page 65)

5.2     Company Stockholders’ Meeting. 
<omitted> 
(f)    <omitted>  (i)     the Company’s board of directors may make a Company Adverse Recommendation Change <omitted> if (and only if): (A) a <omitted> Company Acquisition Proposal is made to the Company <omitted> ; (B) <omitted> such Company Acquisition Proposal constitutes a Company Superior Offer; <omitted> (D) <omitted> prior to making such Company Adverse Recommendation Change <omitted> , the Company’s board of directors delivers to Marvell a <omitted> notice (a “Company Recommendation Change Notice”) 
<omitted> 
For purposes of clause “(i)” of this Section 5.2(f), any change in the form or amount of the consideration payable in connection with a Company Superior Offer, and any other material change to any of the terms of a Company Superior Offer, will be deemed to be a new Company Superior Offer, requiring a new Company Recommendation Change Notice and a new advance notice period, except that the advance notice period applicable to any such change to a Company Superior Offer pursuant to clause “(i)(D)” of this Section 5.2(f) shall be two Business Days rather than three (3) calendar days, and the negotiation period in clause “(i)(E)” of this Section 5.2(f) shall be two Business Days rather than three (3) calendar days. The Company shall ensure that any withdrawal or modification of the Company Board Recommendation does not have the effect of causing any corporate Takeover Statute of the State of Delaware or any other state to be applicable to this Agreement or any of the Contemplated Transactions. (Page 66)

5.2     Company Stockholders’ Meeting. 
<omitted> 
(f)    <omitted>  (i)     the Company’s board of directors may make a Company Adverse Recommendation Change <omitted> if (and only if): (A) a <omitted> Company Acquisition Proposal is made to the Company <omitted> ; (B) <omitted> such Company Acquisition Proposal constitutes a Company Superior Offer; <omitted> (D) <omitted> prior to making such Company Adverse Recommendation Change <omitted> , the Company’s board of directors delivers to Marvell a <omitted> notice (a “Company Recommendation Change Notice”) 
<omitted> 
any change in the form or amount of the consideration payable in connection with a Company Superior Offer, and any other material change to any of the terms of a Company Superior Offer, will be deemed to be a new Company Superior Offer, requiring a new Company Recommendation Change Notice and a new advance notice period, except that the advance notice period applicable to any such change to a Company Superior Offer pursuant to clause “(i)(D)” of this Section 5.2(f) shall be two Business Days rather than three (3) calendar days, and the negotiation period in clause “(i)(E)” of this Section 5.2(f) shall be two Business Days rather than three (3) calendar days. (Page 66)

Question: Initial matching rights period (COR)-Answer
Subquestion: <NONE>
Answer: 3 calendar days